Диссертация (1140384), страница 29
Текст из файла (страница 29)
– Vol. 236, № 1. – P. 137–143.243.Wolter, D.J. Mechanisms of β-lactam resistance among Pseudomonasaeruginosa / D.J. Wolter, P.D. Lister // Current pharmaceutical design. – 2013. –Vol. 19, № 2. – P. 209–222.244.Woodford, N. Comparison of BD Phoenix, Vitek 2, and MicroScan AutomatedSystems for detection and inference of mechanisms responsible for carbapenemresistance in Enterobacteriaceae / N. Woodford, A.T.
Eastaway, M. Ford, A.Leanord, C. Keane, R.M. Quayle, J.A. Steer, J. Zhang, D.M. Livermore // Journal ofClinical Microbiology. – 2010. – Vol. 48, № 8. – P. 2999–3002.245.Woods, D.E. Comparative genomic analysis of Pseudomonas aeruginosavirulence / D.E. Woods. – Trends in Microbiology. – 2004. – № 12. – P. 437–439.246.Xavier, D.E. Efflux pumps expression and its association with porin down-regulation and β-lactamase production among Pseudomonas aeruginosa causingbloodstream infections in Brazil [Электронный ресурс] / D.E. Xavier, R.C.
Picao,R. Girardello, L.C. Fehlberg, A.C. Gales // BMC microbiology. – 2010. –Vol. 10, №217. – Режим доступа: https://www.ncbi.nlm.nih.gov/pubmed/20704733.247.Xipell, M. Successful treatment of three severe MDR or XDR Pseudomonasaeruginosa infections with ceftolozane/tazobactam / M. Xipell, M. Bodro, F.Marco, J.A.
Martinez, A. Soriano // Future Microbiology. – 2017. – №12. – P.1323–1326.177248.Xu, C. Analysis of outer membrane proteome of Escherichia coli related toresistance to ampicillin and tetracycline / C. Xu, X. Lin, H. Ren, Y. Zhang, S. Wang,X. Peng // Proteomics. – 2006. – Vol. 6, № 2. – P. 462–473.249.Yamane, K.
Genetic environments of the rmtA gene in Pseudomonasaeruginosa clinical isolates / K. Yamane, Y. Doi, K. Yokoyama, T. Yagi, H.Kurokawa, N. Shibata, K. Shibayama, H. Kato, Y. Arakawa // Antimicrobial Agentsand Chemotherapy. – 2004. – № 48. – P.2069–2074.250.Yan, A. An undecaprenyl phosphate-aminoarabinose flippase required forpolymyxin resistance in Escherichia coli / A. Yan, Z. Guan, C.R. Raetz // Journal ofBiological Chemistry. – 2007. – № 282.
– P. 36077–36089.251.Yoneyama, H. Nucleotide sequence of the protein D2 gene of Pseudomonasaeruginosa / H. Yoneyama, E. Yoshihara, T. Nakae // Antimicrobial Agents andChemotherapy. – 1992. – № 36. – P. 1791–1793.252.Yoon, S.S. Pseudomonas aeruginosa anaerobic respiration in biofilms:relationships to cystic fibrosis pathogenesis / S.S. Yoon, R.F.Hennigan, G.M.Hilliard, U.A. Ochsner, K. Parvatiyar, M.C. Kamani, H.L. Allen, T,R.
DeKievit,P.R. Gardner, U. Schwab, J.J. Rowe, B.H. Iglewski, T.R. McDermott, R.P.Mason,D.J. Wozniak, R.E.W. Hancock, M.R. Parsek, T.L. Noah, D.J. Hassett //Developmental Cell. – 2002. – Vol. 3, №4. – P. 593–603.253.Yoshihara, E. Protein D2 porin of the Pseudomonas aeruginosa outer membranebears the protease activity / E. Yoshihara, N. Gotoh, T.
Nishino, T. Nakae. – FEBSLetters. – 1996. – Vol. 394, № 2. – P. 179–182.254.Yu, Y.S. Integrons containing the VIM-2 metallo-β-lactamase gene amongimipenem-resistant Pseudomonas aeruginosa strains from different chinesehospitals / Y.S. Yu, T.T. Qu, J.Y. Zhou, J. Wang, H.Y. Li, T.R. Walsh // Journal ofClinical Microbiology.
– 2006. – Vol. 44, №11. – P. 4242–4245.255.Zhang, L. Interactions of bacterial cationic peptide antibiotics with outer andcytoplasmic membranes of Pseudomonas aeruginosa / L. Zhang, P. Dhillon, H.178Yan, S. Farmer, R.E.W Hancock // Antimicrobial Agents and Chemotherapy. –2000. – № 44. – P. 3317–3321.256.Zhou, Y. Distribution of 16S rRNA methylases among different species ofGram-negative bacilli with high-level resistance to aminoglycosides / Y. Zhou, H.Yu, Q. Guo, X.
Xu, X. Ye, S. Wu, Y. Guo, M. Wang // European Journal of ClinicalMicrobiology and Infectious Diseases. – 2010. – № 29. – P. 1349–1353.257.Zincke, D. Characterization of a carbapenem-hydrolyzing enzyme, PoxB, inPseudomonas aeruginosa PAO1 / D. Zincke, D. Balasubramanian, L.L. Silver, K.Mathee // Antimicrobial agents and chemotherapy. – 2016. – Vol. 60, № 2. – P.936–945..














